New drug duo targets advanced cancers in early trial
NCT ID NCT06341114
First seen Jan 06, 2026 · Last updated Apr 24, 2026 · Updated 18 times
Summary
This study tests whether combining two experimental drugs, BAT8008 and BAT1308, is safe and effective for people with advanced solid tumors that have not responded to standard treatments. About 112 adults will take part, first to find the best dose and then to see how well the drugs shrink tumors. The goal is to control the disease, not cure it, and researchers will monitor side effects closely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Song ZhengBo
Hangzhou, Zhejiang, 310005, China
Conditions
Explore the condition pages connected to this study.